NMTC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
NeuroOne Medical Technologies Corp (NMTC) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. While the company has shown significant revenue growth in the latest quarter, the negative net income, declining EPS, and lack of positive trading signals or catalysts suggest that this is not an optimal entry point. The technical indicators and options data also do not provide strong support for a buy decision.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 34.015, and moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 0.733), but there is no strong indication of a reversal. Pivot level is at 0.813, with resistance levels at R1: 0.893 and R2: 0.942.
Gross margin improved to 55.77%, up 7.64% YoY.
Net income dropped by -51.67% YoY, and EPS declined by -72.73% YoY. No recent news or significant trading trends from hedge funds or insiders. No recent congress trading data or influential figure activity. Stock has a 40% chance of a small gain (1.27%) in the next day but a higher chance of a loss (-2.47%) in the next week.
In Q4 2025, revenue increased significantly to $2,740,925 (up 906.64% YoY). However, net income dropped to -$1,619,221 (down -51.67% YoY), and EPS fell to -0.03 (down -72.73% YoY). Gross margin improved to 55.77% (up 7.64% YoY).
No recent analyst ratings or price target changes available.
